Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Jun 10, 2021

30870_dirs_2021-06-10_b803dd02-1039-4357-a87f-361731235d48.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-06-10

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-06-10 Common Stock S 2000 $21.4758 Disposed 158878 Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020.

F2: Includes 2,000 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).